ONCOMATRYX PIONEERING STROMAL MEDICINE
DEAD

Serial Number

79303348

Owner

ONCOMATRYX BIOPHARMA S. L.

Filing Date

Nov 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ONCOMATRYX PIONEERING STROMAL MEDICINE Trademark

Serial Number: 79303348

ONCOMATRYX PIONEERING STROMAL MEDICINE is a trademark filed by ONCOMATRYX BIOPHARMA S. L. on November 24, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ONCOMATRYX BIOPHARMA S. L.

Parque Tecnologico de Bizkaia, Edif 801B

Entity Type: 98

ONCOMATRYX BIOPHARMA, S.A.

Parque Tecnologico de Bizkaia, Edif 801B

Entity Type: 98

Trademark Details

Filing Date

November 24, 2020

Registration Date

Not Registered

Goods & Services

Chemical research and analysis services; research and development of new products for others; preparation of biological samples for use in testing and analysis in research laboratories; analysis of the behavior of chemical substances; scientific and technological services; biomedical research services; scientific and industrial research services; medical and pharmacological research services

Medical services; DNA or RNA testing for cancer diagnosis and prognosis; medical diagnostic services [testing and analysis]; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes

Diagnostic reagents for use in clinical or medical laboratories; diagnostic test reagents for medical use; diagnostic products and materials; products for medical diagnostics; antibodies; pharmaceutical products; chemical preparations for medical use

Tracing material analyzers for medical use in diagnostics; diagnostic testing apparatus for use in immunoassay procedures [medical]; diagnostic testing instruments for use in immunoassay procedures [medical]; surgical apparatus and instruments for medical use

Reagents for medical research; regulatory proteins for scientific use; reagents for chemical analyses; diagnostic reagents for scientific use; laboratory reagents for scientific use; reagents for use in immunoserology; chemical products for use in industry and science

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 16, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 18, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 3, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 13, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 24, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 6, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 6, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 13, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 13, 2021 ABN2
REFUSAL PROCESSED BY IB
Jun 20, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 1, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 1, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 28, 2021 CNRT
ASSIGNED TO EXAMINER
May 10, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2021 REPR